BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 19584266)

  • 1. Targeting of tumor blood vessels: a phage-displayed tumor-homing peptide specifically binds to matrix metalloproteinase-2-processed collagen IV and blocks angiogenesis in vivo.
    Mueller J; Gaertner FC; Blechert B; Janssen KP; Essler M
    Mol Cancer Res; 2009 Jul; 7(7):1078-85. PubMed ID: 19584266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel anti-denatured collagen humanized antibody D93 inhibits angiogenesis and tumor growth: An extracellular matrix-based therapeutic approach.
    Pernasetti F; Nickel J; Clark D; Baeuerle PA; Van Epps D; Freimark B
    Int J Oncol; 2006 Dec; 29(6):1371-9. PubMed ID: 17088974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor targeting with a selective gelatinase inhibitor.
    Koivunen E; Arap W; Valtanen H; Rainisalo A; Medina OP; Heikkilä P; Kantor C; Gahmberg CG; Salo T; Konttinen YT; Sorsa T; Ruoslahti E; Pasqualini R
    Nat Biotechnol; 1999 Aug; 17(8):768-74. PubMed ID: 10429241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting tumor vasculature with homing peptides from phage display.
    Ruoslahti E
    Semin Cancer Biol; 2000 Dec; 10(6):435-42. PubMed ID: 11170865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of endothelial cell interactions with the novel HU177 cryptic collagen epitope inhibits angiogenesis.
    Cretu A; Roth JM; Caunt M; Akalu A; Policarpio D; Formenti S; Gagne P; Liebes L; Brooks PC
    Clin Cancer Res; 2007 May; 13(10):3068-78. PubMed ID: 17505010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
    Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular targeting with phage peptide libraries.
    Pasqualini R
    Q J Nucl Med; 1999 Jun; 43(2):159-62. PubMed ID: 10429511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide-mediated targeting to tumor blood vessels of lung cancer for drug delivery.
    Lee TY; Lin CT; Kuo SY; Chang DK; Wu HC
    Cancer Res; 2007 Nov; 67(22):10958-65. PubMed ID: 18006841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phage peptide display.
    Newton J; Deutscher SL
    Handb Exp Pharmacol; 2008; (185 Pt 2):145-63. PubMed ID: 18626602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In-vivo screening and characterization of peptides specific for vasculature of gastric cancer].
    Wang Y; Wu KC; Nie YZ; Han ZY; Han QL; Qiao TD; Fan DM
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Sep; 19(5):469-72. PubMed ID: 15169660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of synovium-specific homing peptides by in vivo phage display selection.
    Lee L; Buckley C; Blades MC; Panayi G; George AJ; Pitzalis C
    Arthritis Rheum; 2002 Aug; 46(8):2109-20. PubMed ID: 12209516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular addresses of tumors: selection by in vivo phage display.
    Li XB; Schluesener HJ; Xu SQ
    Arch Immunol Ther Exp (Warsz); 2006; 54(3):177-81. PubMed ID: 16736105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. targeted drug delivery to hepatocarcinoma in vivo by phage-displayed specific binding peptide.
    Du B; Han H; Wang Z; Kuang L; Wang L; Yu L; Wu M; Zhou Z; Qian M
    Mol Cancer Res; 2010 Feb; 8(2):135-44. PubMed ID: 20145035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumstatin, the NC1 domain of alpha3 chain of type IV collagen, is an endogenous inhibitor of pathological angiogenesis and suppresses tumor growth.
    Hamano Y; Kalluri R
    Biochem Biophys Res Commun; 2005 Jul; 333(2):292-8. PubMed ID: 15979458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of humanized antibody D93 to sites of angiogenesis and tumor growth by binding to multiple epitopes on denatured collagens.
    Freimark B; Clark D; Pernasetti F; Nickel J; Myszka D; Baeuerle PA; Van Epps D
    Mol Immunol; 2007 Jul; 44(15):3741-50. PubMed ID: 17507095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new phage-display tumor-homing peptide fused to antiangiogenic peptide generates a novel bioactive molecule with antimelanoma activity.
    Matsuo AL; Juliano MA; Figueiredo CR; Batista WL; Tanaka AS; Travassos LR
    Mol Cancer Res; 2011 Nov; 9(11):1471-8. PubMed ID: 21900362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of one vasculature specific phage-displayed peptide in human colon cancer.
    Zhao X; Hu J; Huang R; Yang L
    J Exp Clin Cancer Res; 2007 Dec; 26(4):509-14. PubMed ID: 18365546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide targeting of tumor lymph vessels.
    Laakkonen P; Zhang L; Ruoslahti E
    Ann N Y Acad Sci; 2008; 1131():37-43. PubMed ID: 18519957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-neovascular therapy using novel peptides homing to angiogenic vessels.
    Oku N; Asai T; Watanabe K; Kuromi K; Nagatsuka M; Kurohane K; Kikkawa H; Ogino K; Tanaka M; Ishikawa D; Tsukada H; Momose M; Nakayama J; Taki T
    Oncogene; 2002 Apr; 21(17):2662-9. PubMed ID: 11965539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organ targeting in vivo using phage display peptide libraries.
    Pasqualini R; Ruoslahti E
    Nature; 1996 Mar; 380(6572):364-6. PubMed ID: 8598934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.